StonvexLoading…
StonvexCore line items from CHT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $7.01B | $7.29B | $7.05B | $7.59B |
Operating Income | $1.43B | $1.51B | $1.52B | $1.62B |
Net Income | $1.17B | $1.24B | $1.23B | $1.34B |
EPS (Diluted) | $0.15 | $0.16 | $0.15 | $0.17 |
Total Assets | $16.30B | $17.11B | $17.02B | $18.49B |
Total Liabilities | $4.22B | $4.28B | $4.28B | $4.46B |
Cash & Equivalents | $1.11B | $1.03B | $1.64B | $1.29B |
Free Cash Flow OCF − CapEx | $1.54B | $1.43B | $1.45B | $1.43B |
Shares Outstanding | Not available | Not available | Not available | Not available |